002437 譽衡藥業
按盤價 
2.260 +0.200 (+9.709%)
2.260 +0.200 (+9.709%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.974 | 7.308 | -16.527 | 2.408 | 23.760 |
| 總資產報酬率 ROA (%) | 4.171 | 3.330 | -6.644 | 0.978 | 7.324 |
| 投入資產回報率 ROIC (%) | 5.556 | 4.312 | -8.525 | 1.291 | 13.553 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.032 | 58.389 | 56.925 | 57.528 | 74.042 |
| 營業利潤率 (%) | 12.549 | 6.666 | -8.690 | 3.049 | 18.957 |
| 息稅前利潤/營業總收入 (%) | 12.628 | 7.924 | -7.173 | 5.000 | 21.367 |
| 淨利潤/營業總收入 (%) | 10.769 | 4.901 | -9.315 | 1.712 | 13.378 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 73.843 | 77.354 | -22.987 | 54.757 | -29.641 |
| 價值變動淨收益/利潤總額(%) | -3.167 | -23.404 | 99.959 | -10.831 | 144.225 |
| 營業外收支淨額/利潤總額(%) | -0.129 | 0.979 | -0.151 | -11.540 | -2.477 | 償債能力分析 |
| 流動比率 (X) | 1.043 | 0.817 | 0.777 | 0.822 | 0.703 |
| 速動比率 (X) | 0.822 | 0.682 | 0.686 | 0.690 | 0.557 |
| 資產負債率 (%) | 31.658 | 45.749 | 58.187 | 57.852 | 57.201 |
| 帶息債務/全部投入資本 (%) | 7.044 | 29.498 | 47.661 | 47.104 | -- |
| 股東權益/帶息債務 (%) | 1,300.139 | 234.766 | 107.551 | 110.091 | 128.478 |
| 股東權益/負債合計 (%) | 213.757 | 115.223 | 68.810 | 69.737 | 71.466 |
| 利息保障倍數 (X) | 133.306 | 6.646 | -4.769 | 2.206 | 7.449 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 29.711 | 29.737 | 26.273 | 31.902 | 0.000 |
| 存貨周轉天數 (天) | 60.279 | 66.682 | 76.131 | 97.426 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
